UPDATED: Regeneron Wins Same-Day Veopoz, High-Dose Eylea US FDA Approvals
Products Produced At Same Catalent Site
Veopoz (pozelimab) approval showed the FDA was reassured that Regeneron’s contract manufacturer is ready to supply high-dose Eylea, a key product for the company as competition picks up.
